Literature DB >> 27003724

TP53 mutation, mitochondria and cancer.

William M Kamp1, Ping-Yuan Wang1, Paul M Hwang2.   

Abstract

Under normal conditions, basal levels of wild-type p53 promote mitochondrial function through multiple mechanisms. Remarkably, some missense mutations of p53, in contrast to the null state, can result in the retention of its metabolic activities. These effects are particularly prominent in the mitochondria and demonstrate a functional role for mutant p53 in cancer metabolism. This review summarizes accumulating data on the mechanisms by which p53 missense mutations can regulate mitochondrial metabolism and promote the viability and survival of both normal and cancer cells, thus acting as a double edged sword for the host. Greater understanding of these mechanisms may provide insights for developing new treatment or preventive strategies against cancer. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27003724      PMCID: PMC5028230          DOI: 10.1016/j.gde.2016.02.007

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  85 in total

1.  Mutant p53 protein localized in the cytoplasm inhibits autophagy.

Authors:  Eugenia Morselli; Ezgi Tasdemir; Maria Chiara Maiuri; Lorenzo Galluzzi; Oliver Kepp; Alfredo Criollo; José Miguel Vicencio; Thierry Soussi; Guido Kroemer
Journal:  Cell Cycle       Date:  2008-10-06       Impact factor: 4.534

Review 2.  p53, aerobic metabolism, and cancer.

Authors:  Cory U Lago; Ho Joong Sung; Wenzhe Ma; Ping-yuan Wang; Paul M Hwang
Journal:  Antioxid Redox Signal       Date:  2011-04-14       Impact factor: 8.401

Review 3.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

Review 4.  The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21.

Authors:  Bahman Yousefi; Mohammad Rahmati; Yasin Ahmadi
Journal:  Life Sci       Date:  2014-01-28       Impact factor: 5.037

Review 5.  p53: traffic cop at the crossroads of DNA repair and recombination.

Authors:  Sagar Sengupta; Curtis C Harris
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

6.  Ferroptosis as a p53-mediated activity during tumour suppression.

Authors:  Le Jiang; Ning Kon; Tongyuan Li; Shang-Jui Wang; Tao Su; Hanina Hibshoosh; Richard Baer; Wei Gu
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

7.  Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.

Authors:  Pilar Caro; Amar U Kishan; Erik Norberg; Illana A Stanley; Bjoern Chapuy; Scott B Ficarro; Klaudia Polak; Daniel Tondera; John Gounarides; Hong Yin; Feng Zhou; Michael R Green; Linfeng Chen; Stefano Monti; Jarrod A Marto; Margaret A Shipp; Nika N Danial
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

8.  Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion.

Authors:  Alice Bourdon; Limor Minai; Valérie Serre; Jean-Philippe Jais; Emmanuelle Sarzi; Sophie Aubert; Dominique Chrétien; Pascale de Lonlay; Véronique Paquis-Flucklinger; Hirofumi Arakawa; Yusuke Nakamura; Arnold Munnich; Agnès Rötig
Journal:  Nat Genet       Date:  2007-05-07       Impact factor: 38.330

Review 9.  Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases.

Authors:  Roland Lill; Ulrich Mühlenhoff
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

10.  Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart.

Authors:  Atsushi Hoshino; Yuichiro Mita; Yoshifumi Okawa; Makoto Ariyoshi; Eri Iwai-Kanai; Tomomi Ueyama; Koji Ikeda; Takehiro Ogata; Satoaki Matoba
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more
  24 in total

1.  Lactic acidosis caused by repressed lactate dehydrogenase subunit B expression down-regulates mitochondrial oxidative phosphorylation via the pyruvate dehydrogenase (PDH)-PDH kinase axis.

Authors:  Sun Mi Hong; Young-Kyoung Lee; Imkyong Park; So Mee Kwon; Seongki Min; Gyesoon Yoon
Journal:  J Biol Chem       Date:  2019-03-28       Impact factor: 5.157

2.  Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome.

Authors:  Ping-Yuan Wang; Jie Li; Farzana L Walcott; Ju-Gyeong Kang; Matthew F Starost; S Lalith Talagala; Jie Zhuang; Ji-Hoon Park; Rebecca D Huffstutler; Christina M Bryla; Phuong L Mai; Michael Pollak; Christina M Annunziata; Sharon A Savage; Antonio Tito Fojo; Paul M Hwang
Journal:  J Clin Invest       Date:  2016-11-21       Impact factor: 14.808

3.  The Association Between Polymorphisms in Cell-Cycle Genes and Mitochondrial DNA Copy Number in Coke Oven Workers.

Authors:  Yuping Wang; Jiebing Tan; Wei Wang; Xiaoran Duan; Brooke Lappe; Liuhua Shi; Yongli Yang; Xuezhong Shi
Journal:  Front Public Health       Date:  2022-07-05

4.  Forkhead Box O3A (FOXO3) and the Mitochondrial Disulfide Relay Carrier (CHCHD4) Regulate p53 Protein Nuclear Activity in Response to Exercise.

Authors:  Jie Zhuang; William M Kamp; Jie Li; Chengyu Liu; Ju-Gyeong Kang; Ping-Yuan Wang; Paul M Hwang
Journal:  J Biol Chem       Date:  2016-09-29       Impact factor: 5.157

5.  SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.

Authors:  Jinfang Zhang; Ming Chen; Yasheng Zhu; Xiangpeng Dai; Fabin Dang; Junming Ren; Shancheng Ren; Yulia V Shulga; Francisco Beca; Wenjian Gan; Fei Wu; Yu-Min Lin; Xiaobo Zhou; James A DeCaprio; Andrew H Beck; Kun Ping Lu; Jiaoti Huang; Cheryl Zhao; Yinghao Sun; Xu Gao; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Dev Cell       Date:  2018-12-27       Impact factor: 12.270

6.  Colorectal Cancer and Metabolism.

Authors:  Rachel E Brown; Sarah P Short; Christopher S Williams
Journal:  Curr Colorectal Cancer Rep       Date:  2018-11-16

7.  The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution.

Authors:  Hamish S Scott; Christopher N Hahn; Devendra K Hiwase; Deepak Singhal; Li Yan A Wee; Monika M Kutyna; Rakchha Chhetri; Joel Geoghegan; Andreas W Schreiber; Jinghua Feng; Paul P-S Wang; Milena Babic; Wendy T Parker; Smita Hiwase; Suzanne Edwards; Sarah Moore; Susan Branford; Teodora Kuzmanovic; Nimit Singhal; Raghu Gowda; Anna L Brown; Peer Arts; Luen B To; Peter G Bardy; Ian D Lewis; Richard J D'Andrea; Jaroslaw P Maciejewski
Journal:  Leukemia       Date:  2019-05-14       Impact factor: 11.528

Review 8.  DNA polymerases in the mitochondria: A critical review of the evidence.

Authors:  Rachel Krasich; William C Copeland
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

9.  Pilot Study Assessing Tolerability and Metabolic Effects of Metformin in Patients With Li-Fraumeni Syndrome.

Authors:  Farzana L Walcott; Ping-Yuan Wang; Christine M Bryla; Rebecca D Huffstutler; Neha Singh; Michael N Pollak; Payal P Khincha; Sharon A Savage; Phuong L Mai; Kevin W Dodd; Paul M Hwang; Antonio T Fojo; Christina M Annunziata
Journal:  JNCI Cancer Spectr       Date:  2020-07-18

10.  Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties.

Authors:  James A McCubrey; Akshaya K Meher; Shaw M Akula; Stephen L Abrams; Linda S Steelman; Michelle M LaHair; Richard A Franklin; Alberto M Martelli; Stefano Ratti; Lucio Cocco; Fulvio Barbaro; Przemysław Duda; Agnieszka Gizak
Journal:  Aging (Albany NY)       Date:  2022-04-27       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.